CA
CA · CA · CA-DIN-02423596
INCRUSE ELLIPTA
ATC R03BB07
Last synced from Health Canada Drug Product Database (Canada) on
Identification
ManufacturerGLAXOSMITHKLINE INC
CountryCA (CA)
ATC codeR03BB07
Dispensing—
ReimbursedNo
SourceHealth Canada Drug Product Database (Canada)
Last synced6/11/2026
Packs · 0
No packs registered.
Annotations
No annotations yet.
Raw payload (JSON)
{
"din": "02423596",
"form": "POWDER",
"class": "Human",
"routes": [
"INHALATION"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "R03BB07",
"schedule": [
"Prescription"
],
"drug_code": "90830",
"strengths": [
"62.5 MCG"
],
"ahfs_class": null,
"substances": [
"UMECLIDINIUM (UMECLIDINIUM BROMIDE)"
],
"product_categorization": null
}Related drugs
Other records sharing ATC code R03BB07.
- PLIncruse ElliptaGlaxoSmithKline (Ireland) Limited
- NOIncruse ElliptaGlaxoSmithKline Trading Services Limited
- ISIncruse ElliptaGlaxoSmithKline Trading Services Limited
- 🇨🇭Incruse Ellipta
- 🇺🇸Incruse ElliptaGlaxoSmithKline LLC
- DKIncruse ElliptaGlaxosmithkline Trading Services Limited
- 🇨🇭Incruse ElliptaGlaxoSmithKline AG
- FIIncruse ElliptaGlaxoSmithKline Trading Services Limited
Access this data programmatically
Query INCRUSE ELLIPTA and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.